The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD

The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD

Anna Muñoz,1 Mark Small,2 Robert Wood,3 Anna Ribera,1 Javier Nuevo4 1Formerly of Global Medical Affairs, AstraZeneca PLC, Barcelona, Spain; 2Respiratory Research, Adelphi Real World, Macclesfield, UK; 3Real World Evidence and Epidemiology, Adelphi Real World, Macclesfield, UK; 4Global Me...

Full description

Bibliographic Details
Main Authors:	Muñoz A, Small M, Wood R, Ribera A, Nuevo J
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-05-01
Series:	International Journal of COPD
Subjects:	COPD symptoms healthcare resource utilization activity impairment sleep real-world
Online Access:	https://www.dovepress.com/the-impacts-of-morning-daytime-and-nighttime-symptoms-on-disease-burde-peer-reviewed-article-COPD

Similar Items

COPD symptom burden: impact on health care resource utilization, and work and activity impairment
by: Ding B, et al.
Published: (2017-02-01)

Burden of disease associated with a COPD eosinophilic phenotype
by: Ortega H, et al.
Published: (2018-08-01)

A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD
by: Ding B, et al.
Published: (2017-02-01)

Evaluating the impact of morning symptoms in COPD using the Capacity of Daily Living during the Morning (CDLM) questionnaire
by: Núñez A, et al.
Published: (2018-11-01)

Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI)
by: Hareendran A, et al.
Published: (2018-05-01)

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
by: Wacker ME, et al.
Published: (2017-12-01)

Do patients and carers agree on symptom burden in advanced COPD?
by: Mi E, et al.
Published: (2018-03-01)

COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan
by: Igarashi A, et al.
Published: (2018-08-01)

The association between objectively measured physical activity and morning symptoms in COPD
by: van Buul AR, et al.
Published: (2017-10-01)

A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey
by: Ding B, et al.
Published: (2017-02-01)

Clinical and economic burden of dyspnea and other COPD symptoms in a managed care setting
by: Stephenson JJ, et al.
Published: (2017-07-01)

Symptomatic burden of COPD for patients receiving dual or triple therapy
by: Chen S, et al.
Published: (2018-04-01)

Heterogeneity of asthma and COPD overlap
by: Kim MH, et al.
Published: (2018-04-01)

A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications
by: Ding B, et al.
Published: (2017-05-01)

Trends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010
by: Tsai YH, et al.
Published: (2017-09-01)

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis
by: Miravitlles M, et al.
Published: (2016-08-01)

Use of spirometry and recording of smoking habits of COPD patients increased in primary health care during national COPD programme
by: Lertola Kalle, et al.
Published: (2011-09-01)

Intensity of COPD symptoms in comparison with spirometry parameters
by: Bożena Zboina, et al.
Published: (2019-03-01)

Women manifest more severe COPD symptoms across the life course
by: DeMeo DL, et al.
Published: (2018-10-01)

Economic Burden of COPD by Disease Severity – A Nationwide Cohort Study in Denmark
by: Løkke A, et al.
Published: (2021-03-01)

Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study
by: Ferguson GT, et al.
Published: (2020-11-01)

Understanding the impact of symptoms on the burden of COPD
by: Marc Miravitlles, et al.
Published: (2017-04-01)

Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD
by: Alcazar-Navarrete B, et al.
Published: (2020-10-01)

A single home visit improves adherence and reduces healthcare utilization in patients with frequent exacerbations of Severe Asthma and COPD
by: Anil Ghimire, et al.
Published: (2021-11-01)

The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization
by: Viinanen A, et al.
Published: (2019-10-01)

Effects of aclidinium on determinants of COPD severity: symptoms and quality of life
by: Contoli M, et al.
Published: (2016-12-01)

Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study
by: Florian Kirsch, et al.
Published: (2019-10-01)

Asthma–COPD overlap syndrome in the US: a prospective population-based analysis of patient-reported outcomes and health care utilization
by: Vaz Fragoso CA, et al.
Published: (2017-02-01)

Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD
by: Ke X, et al.
Published: (2016-07-01)

Effects of baseline symptom burden on treatment response in COPD
by: Martinez FJ, et al.
Published: (2019-01-01)

Dyspnea During Night-Time and at Early Morning in Patients with Stable COPD is Associated with Supine Tidal Expiratory Flow Limitation
by: Uccelli S, et al.
Published: (2020-10-01)

High 24-Hour Respiratory Symptoms and Low Physical Activity in the Stable COPD Romanian Cohort of SPACE Study
by: Mihaltan F, et al.
Published: (2021-09-01)

Symptom burden and self-management in persons with chronic obstructive pulmonary disease
by: Bringsvor HB, et al.
Published: (2018-01-01)

Severe COPD cases from Korea, Poland, and USA have substantial differences in respiratory symptoms and other respiratory illnesses
by: Kim WJ, et al.
Published: (2017-11-01)

Community based study to compare the incidence and health services utilization pyramid for gastrointestinal, respiratory and dermal symptoms
by: Najnin Nusrat, et al.
Published: (2012-07-01)

Day and Night Control of COPD and Role of Pharmacotherapy: A Review
by: Braghiroli A, et al.
Published: (2020-06-01)

Impact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohort
by: Kim MA, et al.
Published: (2019-09-01)

The Manchester Respiratory-related Sleep Symptoms scale for patients with COPD: development and validation
by: Khan N, et al.
Published: (2018-11-01)

Clinical Characteristics of COPD Patients According to COPD Assessment Test (CAT) Score Level: Cross-Sectional Study
by: Gil HI, et al.
Published: (2021-06-01)

Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study
by: Gunnar Johansson, et al.
Published: (2018-01-01)